Osteoporosis, bone & mineral

Asian ethnicity is associated with shorter antiresorptive exposure prior to atypical femur fracture (AFF): a Transcontinental Atypical Femoral Fracture Consortium (TrAFFiC) cohort study

J Bone Miner ResPublished Cohort study

Authors' conclusion

In conclusion, Asian individuals sustained AFFs following a shorter duration of anti-resorptive treatment compared with non-Asian AFF peers. In addition, Asian individuals were less likely to sustain additional minimal trauma fractures.

Study context

Population
Patients with atypical femur fractures in the TrAFFiC AFF registry; 77 (46%) with bilateral atypical femur fractures (AFFs), totalling 243 AFFs (138 complete, 105 incomplete)
Participants
166 patients
Exposure
Asian vs non-Asian ethnicity among patients with AFF
  • Asiann = 62
Outcome
"Earlier onset" AFF: AFF sustained following ≤ 5 years of anti-resorptive treatment
Methodological detailsregistry-based, Transcontinental Atypical Femoral Fracture Consortium (TrAFFiC)
  • Registry-based
  • Transcontinental Atypical Femoral Fracture Consortium (TrAFFiC)

Main finding

As reported in the abstract

"Earlier onset" AFF (after ≤ 5 years of anti-resorptive treatment)
Odds ratio (95% CI)P value
Asianvs Non-Asian
2.10(1.06–4.02)
P = 0.034
Southeast AsianSoutheast Asian ethnicity, n=40 (24%)
3.25(1.55–6.8)
P = 0.002

Observational data: associations, not effects.

Further findings

Height

P < 0.038

Weight

P < 0.001

History of minimal trauma fractures prior to AFF

P < 0.001

Teriparatide after incomplete AFF

Teriparatide use following incomplete AFF (n=34) did not affect time to healing or pain resolution

Original publication

Asian ethnicity is associated with shorter antiresorptive exposure prior to atypical femur fracture (AFF): a Transcontinental Atypical Femoral Fracture Consortium (TrAFFiC) cohort study. J Bone Miner Res. Published 16 April 2026. doi:10.1093/jbmr/zjag070

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.